HSE fails to clarify impact of €10m drugs budget cut

As part the HSE’s service plan for 2014, plans to reduce the drug reimbursement scheme budget by €10m were confirmed last December.
The scheme is used to fund vital medications for patients with serious conditions, such as cancer, heart problems and other potentially life-shortening health problems.